ElexoPharm Appoints Prof. Jürgen Engel as Chairman of the Advisory Board
ElexoPharm GmbH announced the appointment of Professor Dr. Jürgen Engel as Chairman of its Advisory Board. He is going to support ElexoPharm’s efforts to expand its activities in preclinical drug development and to build up strong alliances with big pharmaceutical companies. As Chairman of the Advisory Board he will give advice to ElexoPharm on all important strategic and commercial questions.
Currently, Prof. Engel is President and Chief Executive Officer of Æterna Zentaris Inc. in Quebec City, Canada, President of Æterna Zentaris Inc. in Warren, New Jersey, USA and Chairman and Managing Director of Æterna Zentaris GmbH, Frankfurt, Germany. He also serves as Director of the Board of Æterna Zentaris and Isotechnika. Furthermore he is adjunct professor in the School of Pharmacy at the University of Regensburg and Honorary Professor at the Technical University of Dresden.
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.